Author
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Feb. 26, 2021—by Marissa Shapiro Feb. 25, 2021, 8:00 AM A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Jerod Denton Craig Lindsley Leading the collaboration are WCNDD director Craig Lindsley, who holds the William K....
‘This has to be the moment’ to invest in coronavirus vaccines and treatments against future pandemics, warns James Crowe
Feb. 23, 2021—The last thing people will want to think about when this pandemic ends is the next one. It’s human nature to move on, to want to put coronaviruses, vaccines and disease surveillance behind us. But a growing chorus of researchers says now is the time to get ready for what is sure to come. Some have begun preliminary...
Christov & Westover Receive Research Staff Awards
Feb. 18, 2021—Research Staff Awards honor those who help drive engines of discovery Feb. 18, 2021, 9:57 AM by Bill Snyder Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 17th annual Research Staff Awards, held virtually this year because of the pandemic. “We’re really honoring the...
Dean’s Faculty Fellows program recognizes Neuert
Feb. 17, 2021—By Lorena Infante Lara, February 15, 2021 Assistant Professor of Biochemistry Yi Ren and Assistant Professor of Molecular Physiology and Biophysics Gregor Neuert have been recognized as School of Medicine Basic Sciences Dean’s Faculty Fellows. Established in 2020, the Dean’s Faculty Fellows program in Basic Sciences is designed to recognize the efforts of faculty in...
Vanderbilt chemist wins Sloan Research Fellowship
Feb. 17, 2021—by Ann Marie Deer Owens Feb. 16, 2021, 9:22 AM Assistant Professor of Chemistry Steven Townsend (Susan Urmy/Vanderbilt) Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one of the highest honors for young scientists who have the potential to revolutionize their fields of study. Townsend, who previously...
Despite limitations of pandemic, research continues in Basic Sciences
Feb. 10, 2021—Feb. 10, 2021, 8:00 AM By Jenna Somers Vanderbilt researchers are prolific and resolute in their pursuit of transformative research and innovation. During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. On campus and at home, they...
Gene network for leukemia factor
Feb. 5, 2021—Feb. 4, 2021, 9:00 AM by Leigh MacMillan Transcription factors — proteins that regulate gene expression — play critical roles in cell fate decisions and are frequent targets of mutation in a variety of human cancers. Understanding how transcription factors contribute to disease requires the identification of their direct gene targets, but traditional methods are time-consuming and make it difficult to...
Study’s findings may help eventually close the door on COVID-19
Jan. 28, 2021—Jan. 28, 2021, 10:05 AM by Bill Snyder Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles’ heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future pandemics. The coronavirus is an...
A protein that can melt tumors discovered at Vanderbilt
Jan. 28, 2021—by Marissa Shapiro Jan. 27, 2021, 9:00 AM For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days. The article, “MYC regulates ribosome biogenesis and mitochondrial gene expression programs through interaction with Host Cell...
Newly discovered molecule disrupts virus infections through protein quality control pathways
Jan. 27, 2021—by Marissa Shapiro Jan. 26, 2021, 9:00 AM A chemical probe molecule—a “first gen” molecule that can be used for drug development—that targets a host cell’s protein quality control pathways can dramatically reduce infection by Dengue and Zika viruses. The research led by Lars Plate, assistant professor of chemistry and biological sciences, is a significant step...